Perspectives on realising the potential of next-generation sequencing in lung cancer
Medium US,
Lung Cancer Awareness Month (LCAM)is dedicated to promoting symptom awareness to support early diagnosis and highlighting the…
Lung Cancer Awareness Month (LCAM)is dedicated to promoting symptom awareness to support early diagnosis and highlighting the…
A recent survey shows that fewer than half of community oncologists use biomarker testing to guide patient discussions about…
A recent survey shows that fewer than half of community oncologists use biomarker testing to guide patient discussions about…
NEW YORK – A new international survey of experts involved in the care of cancer patients suggests that the incorporation of…
BARCELONA – Molecular testing to guide treatment in patients with lung cancer remains underused, and awareness of related…
BARCELONA – Molecular testing to guide treatment in patients with lung cancer remains underused, and awareness of related…
Karen Titus March 2018—Among the many never-ending chores that humans undertake—paying bills, filing taxes, flossing—writing…
Karen Lusky February 2018—A case of ALK-rearranged lung cancer was the subject of a multidisciplinary molecular tumor board…
Medicine, Health Care Expert Panel Issues New Guidelines… Published: January 30, 2018.
Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease.
Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease.
Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease.
Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease.
Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease.
Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease.
Return to Article List Article ID: 688667 Released: 30-Jan-2018 11:05 AM EST Source Newsroom: University of Colorado Cancer…
Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease.
Home » Top news Jan. 25, 2018—CAP TODAY is hosting a webinar titled “ALK testing for NSCLC: Revised guidelines and new…
DENVER (USA), 25. Januar 2018 (GLOBE NEWSWIRE) -- Rasche Fortschritte in Bezug auf molekulare Tests zur Diagnose von…
A panel of leading experts in molecular pathology has issued new recommendations and updates to guidelines for molecular…
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new…
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new…
GlobeNewswire 2018-01-23 DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of…
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new…
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new…
Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer DENVER, Jan.
Published: January 23, 2018. Released by Brigham and Women's Hospital A panel of leading experts in molecular pathology has…
A panel of leading experts in molecular pathology has issued new recommendations and updates to guidelines for molecular…
Denver, CO, January 23, 2018--Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments…
A panel of leading experts in molecular pathology has issued new recommendations and updates to guidelines for molecular…